SCP & CO Healthcare Acquisition Company Unit
SHACU
SHACU was delisted on the 7th of December, 2022.
63 hedge funds and large institutions have $116M invested in SCP & CO Healthcare Acquisition Company Unit in 2021 Q1 according to their latest regulatory filings, with 63 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$10.2M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$7.84M |
| 3 |
GCL
Glazer Capital LLC
New York
|
+$7.62M |
| 4 |
Millennium Management
New York
|
+$7.09M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$5.84M |
Top Sellers
SHACU Hedge Fund Activity: Q1 2021 in Review
63 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in SCP & CO Healthcare Acquisition Company Unit (SHACU) for Q1 2021, worth a combined $116M.
Buyers outnumbered sellers: 63 funds opened new SHACU positions and 0 closed out — a net gain of 63 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Aristeia Capital, opening a new position worth an estimated $10.2M.
- 63 institutional investors held SCP & CO Healthcare Acquisition Company Unit (SHACU) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $116M of SCP & CO Healthcare Acquisition Company Unit stock for Q1 2021.
- 63 funds opened new SCP & CO Healthcare Acquisition Company Unit positions in Q1 2021 and 0 closed out, a net change of +63 holders.
- The largest SCP & CO Healthcare Acquisition Company Unit buyer in Q1 2021 was Aristeia Capital, an estimated $10.2M added.
Based on aggregated 13F filings for Q1 2021.